MMsInc Molecule/ Ligand PDB

Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02392316

You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.

Ligand	Ligand name	Chain	PDB	Tanimoto	Ligand in PDB
Ligand	Ligand name	Chain	PDB	Tanimoto	Ligand in PDB
FE1	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE	A,B,C,D	2QHX	0.72
DVP	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE	A,B,C,D,E,F, G,H	3H4V	0.73
FOL	FOLIC ACID	A	1PJ6	0.9
FOL	FOLIC ACID	A,B	1RD7	0.9
FOL	FOLIC ACID	A,B	1DHF	0.9
FOL	FOLIC ACID	A,B,C,D,E	1QZF	0.9
FOL	FOLIC ACID	A	4CD2	0.9
FOL	FOLIC ACID	A	1RX7	0.9
FOL	FOLIC ACID	A	1RX2	0.9
FOL	FOLIC ACID	A	1RX8	0.9
FOL	FOLIC ACID	A	1RA2	0.9
FOL	FOLIC ACID	A,B	1RE7	0.9
FOL	FOLIC ACID	A	7DFR	0.9
FOL	FOLIC ACID	A	1VIF	0.9
FOL	FOLIC ACID	A,B	1RB2	0.9
FOL	FOLIC ACID	A	1CD2	0.9
FOL	FOLIC ACID	A	2CD2	0.9
FOL	FOLIC ACID	A,B	1DYI	0.9
FOL	FOLIC ACID	A	1DRF	0.9
FOL	FOLIC ACID	A,B,C,D	3BMC	0.9
FOL	FOLIC ACID	A,B	2D0K	0.9
FOL	FOLIC ACID	A	1RA8	0.9
C92	N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)- 4-methyl-benzene-1,3-dicarboxamide	A,B	3CPB	0.7
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A	1U1J	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A,B	2OGY	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A,B	1XPG	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A,B	1TLS	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A,B,C	1ZP4	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A,B	2E7F	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A	1TSN	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A,B	2IDK	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A,B	1XR2	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A	1B02	0.73
C2F	5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID	A,B	1Q8J	0.73
C24	3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-3-METHYL-3H-BENZOIMIDAZOLE- 5-CARBONYL}-PYRIDIN-2-YL-AMINO)- PROPIONIC ACID ETHYL ESTER	B,C	1KTS	0.72
3BI	(2S)-2-{[(R)-[(3R)-3-carboxy-3- {[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]amino}propyl](hydroxy)phosphoryl]methyl}pentanedioic acid	A	3BI1	0.75
4QB	3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-HEXANOYLAMINO}-4- OXO-BUTYRIC ACID	A	1RWN	0.76
L1C	(2R,4S)-N^1^-(4-chlorophenyl)-4- (2,4-difluorophenyl)-4-hydroxy- N^2^-(2-oxo-2H-1,3'-bipyridin-6'- yl)pyrrolidine-1,2-dicarboxamide	A	2W3I	0.72
L17	L17	A,B	1Z71	0.73
FXA	N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)- 4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE	A	3CEN	0.72
FON	FOLINIC ACID	A,B	1QD1	0.71
FON	FOLINIC ACID	A,B	2BLN	0.71
FON	FOLINIC ACID	A,B,C,D	1VRQ	0.71
FON	FOLINIC ACID	A,B	1KL2	0.71
FON	FOLINIC ACID	A,B	1XZQ	0.71
JIN	6-(2,6-DICHLOROPHENYL)-2-[(4-FLUORO- 3-METHYLPHENYL)AMINO]-8-METHYLPYRIDO[2,3- D]PYRIMIDIN-7(8H)-ONE	A,B	2HZI	0.72
FFO	5-FORMYL-6-HYDROFOLIC ACID	A,B,C,D	1EQB	0.73
FFO	5-FORMYL-6-HYDROFOLIC ACID	A	1JOM	0.73
FFO	5-FORMYL-6-HYDROFOLIC ACID	A	1PJ7	0.73
FFO	5-FORMYL-6-HYDROFOLIC ACID	A,B,C,D	1DFO	0.73
FFO	5-FORMYL-6-HYDROFOLIC ACID	A,B	2VMY	0.73
FFO	5-FORMYL-6-HYDROFOLIC ACID	A,B	1JOL	0.73
FFO	5-FORMYL-6-HYDROFOLIC ACID	A	1WOP	0.73
COP	N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID	A	1OHJ	0.72
COP	N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID	A	1OHK	0.72
3IN	N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY- 3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO- CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)- 3-CHLORO-PYRAZINYL-5-CARBONYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL- PENTANAMIDE	B	2BPZ	0.72
3IN	N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY- 3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO- CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)- 3-CHLORO-PYRAZINYL-5-CARBONYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL- PENTANAMIDE	B	2BPY	0.72
3IN	N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY- 3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO- CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)- 3-CHLORO-PYRAZINYL-5-CARBONYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL- PENTANAMIDE	B	1C6X	0.72
GPB	N-[4-[2-(2-AMINO-4-METHYL-7H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYL]GLUTAMIC ACID	A	1E26	0.7
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1KCE	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1NCE	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B,C,D,E,F	1KZJ	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	X	2FTO	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A	1TRG	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	2TSC	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A	1TVU	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A	1TVV	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1FWM	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1BQ1	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B,C,D,E	3DL5	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1AIQ	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1DDU	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B,C,D,E	1QZF	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1TDU	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A	1VZE	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	2G8M	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B,C,D,E	2OIP	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1CI7	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1DNA	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A	1LCA	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A	1VZD	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1ZPR	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P	2AAZ	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	2G8O	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A	1TVW	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B,C,D,E	3DL6	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B	1AN5	0.71
CB3	10-PROPARGYL-5,8-DIDEAZAFOLIC ACID	A,B,C,D	2BFA	0.71
DHF	DIHYDROFOLIC ACID	A,B,C,D,E	3DL5	0.73
DHF	DIHYDROFOLIC ACID	A	1LCB	0.73
DHF	DIHYDROFOLIC ACID	A,B,C,D	1MXH	0.73
DHF	DIHYDROFOLIC ACID	A	2RK1	0.73
DHF	DIHYDROFOLIC ACID	A	1RF7	0.73
DHF	DIHYDROFOLIC ACID	A,B,C,D,E	3DL6	0.73
DHF	DIHYDROFOLIC ACID	A	1TYS	0.73
DZF	5-DEAZAFOLIC ACID	A,B	2DHF	0.84
DZF	5-DEAZAFOLIC ACID	A,B	1DYH	0.84
DZF	5-DEAZAFOLIC ACID	A,B,C,D	1CDE	0.84